Dan Levy

Stock Analyst at Barclays

(1.40)
# 3,361
Out of 4,876 analysts
269
Total ratings
37.16%
Success rate
-12.78%
Average return

Stocks Rated by Dan Levy

Dana Incorporated
Jun 12, 2025
Maintains: Overweight
Price Target: $20$25
Current: $17.28
Upside: +44.68%
Gauzy
May 14, 2025
Maintains: Overweight
Price Target: $15$13
Current: $9.09
Upside: +43.01%
First Watch Restaurant Group
May 6, 2025
Maintains: Overweight
Price Target: $24$20
Current: $16.47
Upside: +21.43%
Ford Motor Company
May 6, 2025
Maintains: Equal-Weight
Price Target: $8$9
Current: $10.63
Upside: -15.33%
General Motors Company
May 5, 2025
Maintains: Equal-Weight
Price Target: $40$45
Current: $49.16
Upside: -8.46%
Aptiv
May 5, 2025
Maintains: Equal-Weight
Price Target: $55$65
Current: $67.94
Upside: -4.33%
Autoliv
Apr 21, 2025
Maintains: Overweight
Price Target: $97$105
Current: $111.13
Upside: -5.52%
Tesla
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $325$275
Current: $325.78
Upside: -15.59%
Magna International
Apr 15, 2025
Maintains: Equal-Weight
Price Target: $47$37
Current: $38.28
Upside: -3.34%
Lear Corporation
Apr 15, 2025
Maintains: Equal-Weight
Price Target: $115$85
Current: $94.03
Upside: -9.60%
Maintains: Overweight
Price Target: $42$35
Current: $33.60
Upside: +4.17%
Maintains: Equal-Weight
Price Target: $21$13
Current: $19.71
Upside: -34.04%
Downgrades: Equal-Weight
Price Target: $22$14
Current: $18.44
Upside: -24.08%
Downgrades: Equal-Weight
Price Target: $110$82
Current: $93.34
Upside: -12.15%
Maintains: Equal-Weight
Price Target: $13$14
Current: $13.91
Upside: +0.65%
Maintains: Equal-Weight
Price Target: $8$7
Current: $4.20
Upside: +66.67%
Initiates: Underweight
Price Target: $3
Current: $7.56
Upside: -60.32%
Initiates: Equal-Weight
Price Target: $105
Current: $179.30
Upside: -41.44%
Maintains: Underweight
Price Target: $2$1
Current: $1.10
Upside: -9.09%
Maintains: Equal-Weight
Price Target: $40$43
Current: $24.34
Upside: +76.66%
Initiates: Outperform
Price Target: $330
Current: $2.95
Upside: +11,086.44%
Initiates: Outperform
Price Target: $30
Current: $33.56
Upside: -10.61%